Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GERN:US

3.8100 USD 0.0500 1.30%

As of 15:56:06 ET on 06/02/2015.

Company Profile for Geron Corp (GERN)

Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Contact Information

Geron Corp

230 Consititution Drive
Menlo Park, CA 94025
United States
Phone: 1-650-473-7700
Fax: 1-650-473-7750

Key Executives for Geron Corp (GERN)

Hoyoung HuhChairmanJohn A ScarlettPresident/CEO
Stephen N RosenfieldExec VP/Secy/Gen CnslMelissa A Kelly BehrsExec VP:Business Development
Andrew J Grethlein "Andy"Exec VP:Dev & Tech OperationsOlivia K BloomExec VP:Finance/CFO/Treasurer
Anna KrassowskaInvestor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil